Cetuximab - PDFSEARCH.IO - Document Search Engine

Cetuximab
Results: 236

#	Item
61	Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Cetuximab Health Scottish Medicines Consortium Omalizumab Interferon Alternative medicine Bevacizumab Rosacea Medicine Pharmacology Bristol-Myers Squibb
62	Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 The Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee (PBAC) held its 78th meeting on 6-7 June[removed]DUSC is a national Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Healthcare in Australia Pharmaceuticals policy Pharmaceutical Benefits Scheme Quality use of medicines Drug safety Fingolimod Cetuximab Pharmacovigilance Antipsychotic Medicine Pharmacology Health
63	60th MSAC Meeting 28 November 2013 PBAC referral relevant to Applications 1362 and 1363 – KRAS/RAS testing under MBS item[removed]for access to cetuximab/panitumumab Summary of consideration and rationale for MSAC’s ad Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:11 Cetuximab Biotechnology Panitumumab KRAS Oncogenes Immune system Colorectal cancer Ras subfamily Biomarker Medicine Biology Bristol-Myers Squibb
64	Drug Utilisation Sub-Committee Outcome Statement 6-7 June 2013 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:20:02 Healthcare in Australia Pharmaceuticals policy Pharmaceutical Benefits Scheme Quality use of medicines Drug safety Fingolimod Cetuximab Pharmacovigilance Antipsychotic Medicine Pharmacology Health
65	60th MSAC Meeting 28 November[removed]PBAC referral relevant to Applications 1362 and 1363 – KRAS/RAS testing under MBS item[removed]for access to cetuximab/panitumumab Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-03 00:24:10 Cetuximab Biotechnology Panitumumab KRAS Oncogenes Immune system Colorectal cancer Ras subfamily Biomarker Medicine Biology Bristol-Myers Squibb
66	Medical Services Advisory Committee Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2013-11-01 01:33:24 KRAS Oncology Gastrointestinal cancer Colorectal cancer Cancer Metastasis Pharmaceutical Benefits Scheme Medicine Bristol-Myers Squibb Cetuximab
67	news Inside this issue • Cystic Fibrosis Investigations • 25-hydroxy Vitamin D • KRAS Testing Add to Reading List Source URL: www.pathologynorth.com.au Language: English - Date: 2013-01-14 21:15:57 Channelopathy Cystic fibrosis Pediatrics Sweat test Ivacaftor Epithelial sodium channel Cetuximab KRAS Congenital absence of the vas deferens Medicine Health Biology
68	National Cancer Drugs Fund List Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2015-03-12 13:47:34 Organochlorides Organofluorides Bevacizumab Cetuximab Head and neck cancer Radiation therapy Adjuvant therapy Prostate cancer Renal cell carcinoma Medicine Cancer treatments Orphan drugs
69	ARTICLE Received 3 Oct 2014 \| Accepted 22 Dec 2014 \| Published 27 Feb 2015 DOI: [removed]ncomms7169 OPEN Add to Reading List Source URL: www.nature.com Language: English - Date: 2015-02-27 07:56:38 Tyrosine kinase receptors Oncology Epidermal growth factor receptor Ras subfamily Panitumumab HER2/neu Cetuximab Biology Medicine Oncogenes
70	Microsoft WordCRC Disease Site Schema Add to Reading List Source URL: www.ucdenver.edu Language: English - Date: 2015-04-03 14:22:01 Oncology Bristol-Myers Squibb Cetuximab Gastrointestinal cancer Bevacizumab Colorectal cancer FOLFIRI FOLFOX Irinotecan Medicine Pharmacology Chemotherapy regimens

UPDATE